Search This Blog

Thursday, November 7, 2019

Clovis Oncology EPS beats by $0.17, beats on revenue

Clovis Oncology (NASDAQ:CLVS): Q3 GAAP EPS of -$1.72 beats by $0.17.
Revenue of $37.6M (+65.2% Y/Y) beats by $1.76M.
Shares +10.7% PM.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)